These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 111115)

  • 1. Unstable, non-mutational expression of resistance to the thymidine analogue, trifluorothymidine in CHO cells.
    Adair GM; Carver JH
    Mutat Res; 1979 Apr; 60(2):207-13. PubMed ID: 111115
    [No Abstract]   [Full Text] [Related]  

  • 2. Quantitation of small colony trifluorothymidine-resistant mutants of L5178Y/TK+/- mouse lymphoma cells in RPMI-1640 medium.
    Moore MM; Howard BE
    Mutat Res; 1982; 104(4-5):287-94. PubMed ID: 6810164
    [No Abstract]   [Full Text] [Related]  

  • 3. Trifluorothymidine resistance and colony size in L5178Y/TK +/- cells treated with methyl methanesulfonate.
    Amacher DE; Paillet SC
    J Cell Physiol; 1981 Mar; 106(3):349-60. PubMed ID: 6783669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thymidine kinase activity and trifluorothymidine resistance of spontaneous and mutagen-induced L5178Y cells in RPMI 1640 medium.
    Oberly TJ; Bewsey BJ; Probst GS
    Mutat Res; 1986 Jul; 161(2):165-71. PubMed ID: 3088439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On the molecular mechanism of the antiviral activity of trifluorothymidine.
    Heidelberger C
    Ann N Y Acad Sci; 1975 Aug; 255():317-25. PubMed ID: 171993
    [No Abstract]   [Full Text] [Related]  

  • 6. The utilization of trifluorothymidine (TFT) to select for thymidine kinase-deficient (TK-/-) mutants from L5178Y/TK+/- mouse lymphoma cells.
    Moore-Brown MM; Clive D; Howard BE; Batson AG; Johnson KO
    Mutat Res; 1981 Oct; 85(5):363-78. PubMed ID: 6795499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of acycloguanosine and trifluorothymidine as inhibitors of cytomegalovirus infection in vitro.
    Lang DJ; Cheung KS
    Am J Med; 1982 Jul; 73(1A):49-53. PubMed ID: 6285732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trifluorothymidine and 5-fluorouracil: antiproliferative activity in tissue culture.
    Rivera AH; Hajek AS; Fantes F; Mallick KS; Parrish RK
    Can J Ophthalmol; 1987 Feb; 22(1):13-6. PubMed ID: 3102027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do trifluorothymidine-resistant mutants of L5178Y mouse lymphoma cells re-express thymidine kinase activity following 5-azacytidine treatment?
    Moore MM; Applegate ML; Hozier JC
    Mutat Res; 1988 Feb; 207(2):77-82. PubMed ID: 2448615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced inhibition of virus DNA synthesis in hepatocytes by trifluorothymidine coupled to asialofetuin.
    Fiume L; Mattioli A; Balboni PG; Tognon M; Barbanti-Brodano G; de Vries J; Wieland T
    FEBS Lett; 1979 Jul; 103(1):47-51. PubMed ID: 89047
    [No Abstract]   [Full Text] [Related]  

  • 11. Mutagenicity testing in mammalian cells. II. Validation of multiple drug-resistance markers having practical application for screening potential mutagens.
    Carver JH; Adair GM; Wandres DL
    Mutat Res; 1980 Sep; 72(2):207-30. PubMed ID: 6449664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth inhibition of cells in cultures and of vaccinia virus infected HeLa cells by derivatives of trifluorothymidine.
    Parkhurst JR; Danenberg PV; Heidelberger C
    Chemotherapy; 1976; 22(3-4):221-31. PubMed ID: 178485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In situ analysis of trifluorothymidine-resistant (TFTr) mutants of L5178Y/TK+/- mouse lymphoma cells.
    Moore MM; Clive D; Howard BE; Batson AG; Turner NT
    Mutat Res; 1985 Aug; 151(1):147-59. PubMed ID: 3927156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trifluridine: a review of its antiviral activity and therapeutic use in the topical treatment of viral eye infections.
    Carmine AA; Brogden RN; Heel RC; Speight TM; Avery GS
    Drugs; 1982 May; 23(5):329-53. PubMed ID: 6284470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Epithel regeneration inhibition in the treatment of Trifluorothymidin (F3TDR) (author's transl)].
    Holtmann HW; Stein HJ
    Klin Monbl Augenheilkd; 1977 Oct; 171(4):576-9. PubMed ID: 412994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repeated mutagenesis and the selection of recessive and dominant mutations in cultured mammalian cells.
    Gupta RS
    Mutat Res; 1980 Dec; 74(6):503-8. PubMed ID: 6936610
    [No Abstract]   [Full Text] [Related]  

  • 17. Analysis of trifluorothymidine-resistant (TFTr) mutants of L5178Y/TK+/- mouse lymphoma cells.
    Moore MM; Clive D; Hozier JC; Howard BE; Batson AG; Turner NT; Sawyer J
    Mutat Res; 1985 Aug; 151(1):161-74. PubMed ID: 3927157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence obtained by induced mutation frequency analysis for functional hemizygosity at the emt locus in CHO cells.
    Campbell CE; Worton RG
    Somatic Cell Genet; 1979 Jan; 5(1):51-65. PubMed ID: 432757
    [No Abstract]   [Full Text] [Related]  

  • 19. [Superficial herpetic keratitis : comparative treatment with trifluorothymidine or the combination isoprinosine-trifluorothymidine].
    Colin J; Bonissent JF; Renard G
    Bull Soc Ophtalmol Fr; 1982; 82(6-7):779-81. PubMed ID: 6184179
    [No Abstract]   [Full Text] [Related]  

  • 20. Mutagenicity testing in mammalian cells. I. Derivation of a Chinese hamster ovary cell line heterozygous for the adenine phosphoribosyltransferase and thymidine kinase loci.
    Adair GM; Carver JH; Wandres DL
    Mutat Res; 1980 Sep; 72(2):187-205. PubMed ID: 6449663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.